ANTM). If you want access to this report all you need to do is sign up now by clicking the following link www.active-investors.com/registration-sg/?symbol=ANTM. Anthem reported its fourth quarter and fiscal 2017 operating and financial results on January 31, 2018. The health insurer surpassed top- and bottom-line expectations and provided guidance for the fiscal year 2018. Register today and get access to over 1,000 Free Research Reports by joining our site below:

www.active-investors.com/registration-sg

Active-Investors.com is currently working on the research report for WellCare Health Plans, Inc. (NYSE: WCG), which also belongs to the Healthcare sector as the Company Anthem. Do not miss out and become a member today for free to access this upcoming report at:

www.active-investors.com/registration-sg/?symbol=WCG

Active-Investors.com is focused on giving you timely information and the inside line on companies that matter to you. This morning, Anthem most recent news is on our radar and our team decided to put out a fantastic report on the company that is now available for free below:

www.active-investors.com/registration-sg/?symbol=ANTM

Earnings Highlights and Summary

Anthem's operating revenue was $22.45 billion in Q4 2017, reflecting growth of 4.5% versus revenue of $21.48 billion in Q4 2016. The growth in revenue reflected premium rate increases to cover overall cost trends across the Company's business. Additionally, the increase was driven by higher enrollment in Medicare and both Local Group insured and self-funded businesses. Anthem's reported numbers exceeded analysts' estimates by $200 million.

For full year (FY) 2017, Anthem reported operating revenue of $89.06 billion, up 5.8% compared to operating revenue of $84.19 billion in FY16.

During Q4 2017, Anthem recorded a one-time, non-cash deferred tax benefit from corporate tax reform of $1.1 billion, reducing the total income tax expense in FY17 to $121 million, an effective tax rate of 3.1%.

For Q4 2017, Anthem reported net income of $1.23 billion, or $4.67 per diluted shares, compared to $368.4 million, or $1.37 per diluted share, in Q4 2016. On an adjusted basis, the Company reported net income of $338.8 million, or $1.29 per share, versus $473.2 million, or $1.76 per diluted share, in the prior year's comparable quarter. Anthem's earnings beat Wall Street's estimates of $1.25 per share.

For FY17, Anthem recorded net income of $3.84 billion, or $14.35 per diluted shares, compared to $2.47 billion, or $9.21 per diluted share, in FY16. On an adjusted basis, the Company posted net income of $3.22 billion, or $12.04 per share, compared to $2.95 billion, or $11.00 per diluted share, in FY16.

Operating Details

Anthem's Medical enrollment totaled approximately 40.2 million members at December 31, 2017, an increase of 0.8% from 39.9 million members at December 31, 2016. Commercial & Specialty Business enrollment increased by 278,000 medical members on a y-o-y basis, as the Company experienced growth in both self-funded and fully-insured Local Group businesses. Enrollment also grew by 47,000 in the Government business.

During Q4 2017, Anthem's Medical enrollment declined by 13,000 lives sequentially, reflecting enrollment declines in the Individual business, partially offset by growth in the Medicare, Medicaid, and Local Group self-funded businesses.

Anthem's benefit expense ratio was 88.6% in Q4 2017, reflecting an increase of 140 basis points from 87.2% in Q4 2016. The increase was principally driven by the impact of the one-year waiver of the health insurance tax in 2017.

Anthem's Days in Claims Payable (DCP) was 39.4 days as of December 31, 2017, representing a decrease of 1.1 days from 40.5 days as of September 30, 2017.

Segment Results

During Q4 2017, Anthem's operating gain in the Commercial & Specialty Business segment totaled $71.2 million, down 62.4% from $189.2 million in Q4 2016. The decrease was driven by increased investment spending to support growth initiatives and the impact of the one-year waiver of the health insurance tax in 2017.

Anthem's operating gain in the Government Business segment was $360.8 million in Q4 2017, reflecting a decrease of 31.9%, from $529.9 million in Q4 2016. The decrease reflects increased investment spend to support growth initiatives and the impact of the one-year waiver of the health insurance tax in 2017.

Cash Matters

During Q4 2017, Anthem's operating cash outflow was $1.3 billion, bringing FY17 operating cash flow to $4.2 billion, or 1.1 times net income.

During Q4 2017, the Company repurchased 1.8 million shares of its common stock for $362 million, or a weighted-average price of $205.41. During FY17, Anthem repurchased 10.5 million shares of its common stock for $2.0 billion, or a weighted average price of $189.93. As of December 31, 2017, the Company had approximately $7.2 billion of Board-approved share repurchase authorization remaining.

Outlook

For full year 2018, Anthem is forecasting net income to be greater than $14.28 per share, including approximately $0.72 per share of net unfavorable items. The Company's adjusted net income is expected to be greater than $15.00 per share.

For FY18, Anthem is projecting Medical membership to be in the range of 40.00 million to 40.20 million, fully insured membership is expected to be in the band of 14.80 million to 14.90 million and self-funded membership is expected to be in the range of 25.20 million to 25.30 million.

Anthem is estimating operating revenue to be in the range of $90.5 billion to $91.5 billion for FY18. The Company is anticipating benefit expense ratio to be 84.5% plus or minus 30 basis points and operating cash flow is expected to be greater than $4.0 billion.

Stock Performance Snapshot

February 13, 2018 - At Tuesday's closing bell, Anthem's stock marginally rose 0.29%, ending the trading session at $233.45.

Volume traded for the day: 1.39 million shares.

Stock performance in the last three-month – up 6.95%; previous six-month period – up 22.03%; past twelve-month period – up 42.77%; and year-to-date – up 3.75%

After yesterday's close, Anthem's market cap was at $60.81 billion.

Price to Earnings (P/E) ratio was at 16.25.

The stock has a dividend yield of 1.29%.

The stock is part of the Healthcare sector, categorized under the Health Care Plans industry. This sector was up 0.1% at the end of the session.

Active-Investors:

Active-Investors (A-I) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and Canadian stocks. A-I has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

A-I has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third-party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email info@active-investors.com. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by A-I. A-I is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

A-I, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. A-I, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, A-I, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither A-I nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://active-investors.com/legal-disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@active-investors.com

Phone number: 73 29 92 6381

Office Address: 6, Jalan Kia Peng, Kuala Lumpur, 50450 Kuala Lumpur, Wilayah Persekutuan Kuala Lumpur, Malaysia

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active-Investors

ReleaseID: 489221

"/> Free Research Report as Anthem’s Quarterly Revenue Grew 4.5%; Earnings More Than Tripled « MarketersMedia – Press Release Distribution Services – News Release Distribution Services
Great News! MarketersMedia is officially entering into a long-term partnership with Vertical News Network.
Learn More
How It Works? Plans & Pricing Our Distributions Newsroom Info Hub Sign Up Sign In Send Press Release Contact Sales
Contact Sales Sign Up Your Account Send Press Release
MarketersMEDIA / Newsroom / Free Research Report as Anthem’s Quarterly Revenue Grew 4.5%; Earnings More Than Tripled

Free Research Report as Anthem’s Quarterly Revenue Grew 4.5%; Earnings More Than Tripled

Share This Press Release

Stock Monitor: WellCare Health Plans Post Earnings Reporting

LONDON, UK / ACCESSWIRE / February 14, 2018 / Active-Investors.com has just released a free earnings report on Anthem, Inc. (NYSE: ANTM). If you want access to this report all you need to do is sign up now by clicking the following link www.active-investors.com/registration-sg/?symbol=ANTM. Anthem reported its fourth quarter and fiscal 2017 operating and financial results on January 31, 2018. The health insurer surpassed top- and bottom-line expectations and provided guidance for the fiscal year 2018. Register today and get access to over 1,000 Free Research Reports by joining our site below:

www.active-investors.com/registration-sg

Active-Investors.com is currently working on the research report for WellCare Health Plans, Inc. (NYSE: WCG), which also belongs to the Healthcare sector as the Company Anthem. Do not miss out and become a member today for free to access this upcoming report at:

www.active-investors.com/registration-sg/?symbol=WCG

Active-Investors.com is focused on giving you timely information and the inside line on companies that matter to you. This morning, Anthem most recent news is on our radar and our team decided to put out a fantastic report on the company that is now available for free below:

www.active-investors.com/registration-sg/?symbol=ANTM

Earnings Highlights and Summary

Anthem's operating revenue was $22.45 billion in Q4 2017, reflecting growth of 4.5% versus revenue of $21.48 billion in Q4 2016. The growth in revenue reflected premium rate increases to cover overall cost trends across the Company's business. Additionally, the increase was driven by higher enrollment in Medicare and both Local Group insured and self-funded businesses. Anthem's reported numbers exceeded analysts' estimates by $200 million.

For full year (FY) 2017, Anthem reported operating revenue of $89.06 billion, up 5.8% compared to operating revenue of $84.19 billion in FY16.

During Q4 2017, Anthem recorded a one-time, non-cash deferred tax benefit from corporate tax reform of $1.1 billion, reducing the total income tax expense in FY17 to $121 million, an effective tax rate of 3.1%.

For Q4 2017, Anthem reported net income of $1.23 billion, or $4.67 per diluted shares, compared to $368.4 million, or $1.37 per diluted share, in Q4 2016. On an adjusted basis, the Company reported net income of $338.8 million, or $1.29 per share, versus $473.2 million, or $1.76 per diluted share, in the prior year's comparable quarter. Anthem's earnings beat Wall Street's estimates of $1.25 per share.

For FY17, Anthem recorded net income of $3.84 billion, or $14.35 per diluted shares, compared to $2.47 billion, or $9.21 per diluted share, in FY16. On an adjusted basis, the Company posted net income of $3.22 billion, or $12.04 per share, compared to $2.95 billion, or $11.00 per diluted share, in FY16.

Operating Details

Anthem's Medical enrollment totaled approximately 40.2 million members at December 31, 2017, an increase of 0.8% from 39.9 million members at December 31, 2016. Commercial & Specialty Business enrollment increased by 278,000 medical members on a y-o-y basis, as the Company experienced growth in both self-funded and fully-insured Local Group businesses. Enrollment also grew by 47,000 in the Government business.

During Q4 2017, Anthem's Medical enrollment declined by 13,000 lives sequentially, reflecting enrollment declines in the Individual business, partially offset by growth in the Medicare, Medicaid, and Local Group self-funded businesses.

Anthem's benefit expense ratio was 88.6% in Q4 2017, reflecting an increase of 140 basis points from 87.2% in Q4 2016. The increase was principally driven by the impact of the one-year waiver of the health insurance tax in 2017.

Anthem's Days in Claims Payable (DCP) was 39.4 days as of December 31, 2017, representing a decrease of 1.1 days from 40.5 days as of September 30, 2017.

Segment Results

During Q4 2017, Anthem's operating gain in the Commercial & Specialty Business segment totaled $71.2 million, down 62.4% from $189.2 million in Q4 2016. The decrease was driven by increased investment spending to support growth initiatives and the impact of the one-year waiver of the health insurance tax in 2017.

Anthem's operating gain in the Government Business segment was $360.8 million in Q4 2017, reflecting a decrease of 31.9%, from $529.9 million in Q4 2016. The decrease reflects increased investment spend to support growth initiatives and the impact of the one-year waiver of the health insurance tax in 2017.

Cash Matters

During Q4 2017, Anthem's operating cash outflow was $1.3 billion, bringing FY17 operating cash flow to $4.2 billion, or 1.1 times net income.

During Q4 2017, the Company repurchased 1.8 million shares of its common stock for $362 million, or a weighted-average price of $205.41. During FY17, Anthem repurchased 10.5 million shares of its common stock for $2.0 billion, or a weighted average price of $189.93. As of December 31, 2017, the Company had approximately $7.2 billion of Board-approved share repurchase authorization remaining.

Outlook

For full year 2018, Anthem is forecasting net income to be greater than $14.28 per share, including approximately $0.72 per share of net unfavorable items. The Company's adjusted net income is expected to be greater than $15.00 per share.

For FY18, Anthem is projecting Medical membership to be in the range of 40.00 million to 40.20 million, fully insured membership is expected to be in the band of 14.80 million to 14.90 million and self-funded membership is expected to be in the range of 25.20 million to 25.30 million.

Anthem is estimating operating revenue to be in the range of $90.5 billion to $91.5 billion for FY18. The Company is anticipating benefit expense ratio to be 84.5% plus or minus 30 basis points and operating cash flow is expected to be greater than $4.0 billion.

Stock Performance Snapshot

February 13, 2018 - At Tuesday's closing bell, Anthem's stock marginally rose 0.29%, ending the trading session at $233.45.

Volume traded for the day: 1.39 million shares.

Stock performance in the last three-month – up 6.95%; previous six-month period – up 22.03%; past twelve-month period – up 42.77%; and year-to-date – up 3.75%

After yesterday's close, Anthem's market cap was at $60.81 billion.

Price to Earnings (P/E) ratio was at 16.25.

The stock has a dividend yield of 1.29%.

The stock is part of the Healthcare sector, categorized under the Health Care Plans industry. This sector was up 0.1% at the end of the session.

Active-Investors:

Active-Investors (A-I) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and Canadian stocks. A-I has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

A-I has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third-party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email info@active-investors.com. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by A-I. A-I is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

A-I, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. A-I, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, A-I, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither A-I nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://active-investors.com/legal-disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@active-investors.com

Phone number: 73 29 92 6381

Office Address: 6, Jalan Kia Peng, Kuala Lumpur, 50450 Kuala Lumpur, Wilayah Persekutuan Kuala Lumpur, Malaysia

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active-Investors

ReleaseID: 489221

Stock Monitor: WellCare Health Plans Post Earnings Reporting

LONDON, UK / ACCESSWIRE / February 14, 2018 / Active-Investors.com has just released a free earnings report on Anthem, Inc. (NYSE: ANTM). If you want access to this report all you need to do is sign up now by clicking the following link www.active-investors.com/registration-sg/?symbol=ANTM. Anthem reported its fourth quarter and fiscal 2017 operating and financial results on January 31, 2018. The health insurer surpassed top- and bottom-line expectations and provided guidance for the fiscal year 2018. Register today and get access to over 1,000 Free Research Reports by joining our site below:

www.active-investors.com/registration-sg

Active-Investors.com is currently working on the research report for WellCare Health Plans, Inc. (NYSE: WCG), which also belongs to the Healthcare sector as the Company Anthem. Do not miss out and become a member today for free to access this upcoming report at:

www.active-investors.com/registration-sg/?symbol=WCG

Active-Investors.com is focused on giving you timely information and the inside line on companies that matter to you. This morning, Anthem most recent news is on our radar and our team decided to put out a fantastic report on the company that is now available for free below:

www.active-investors.com/registration-sg/?symbol=ANTM

Earnings Highlights and Summary

Anthem's operating revenue was $22.45 billion in Q4 2017, reflecting growth of 4.5% versus revenue of $21.48 billion in Q4 2016. The growth in revenue reflected premium rate increases to cover overall cost trends across the Company's business. Additionally, the increase was driven by higher enrollment in Medicare and both Local Group insured and self-funded businesses. Anthem's reported numbers exceeded analysts' estimates by $200 million.

For full year (FY) 2017, Anthem reported operating revenue of $89.06 billion, up 5.8% compared to operating revenue of $84.19 billion in FY16.

During Q4 2017, Anthem recorded a one-time, non-cash deferred tax benefit from corporate tax reform of $1.1 billion, reducing the total income tax expense in FY17 to $121 million, an effective tax rate of 3.1%.

For Q4 2017, Anthem reported net income of $1.23 billion, or $4.67 per diluted shares, compared to $368.4 million, or $1.37 per diluted share, in Q4 2016. On an adjusted basis, the Company reported net income of $338.8 million, or $1.29 per share, versus $473.2 million, or $1.76 per diluted share, in the prior year's comparable quarter. Anthem's earnings beat Wall Street's estimates of $1.25 per share.

For FY17, Anthem recorded net income of $3.84 billion, or $14.35 per diluted shares, compared to $2.47 billion, or $9.21 per diluted share, in FY16. On an adjusted basis, the Company posted net income of $3.22 billion, or $12.04 per share, compared to $2.95 billion, or $11.00 per diluted share, in FY16.

Operating Details

Anthem's Medical enrollment totaled approximately 40.2 million members at December 31, 2017, an increase of 0.8% from 39.9 million members at December 31, 2016. Commercial & Specialty Business enrollment increased by 278,000 medical members on a y-o-y basis, as the Company experienced growth in both self-funded and fully-insured Local Group businesses. Enrollment also grew by 47,000 in the Government business.

During Q4 2017, Anthem's Medical enrollment declined by 13,000 lives sequentially, reflecting enrollment declines in the Individual business, partially offset by growth in the Medicare, Medicaid, and Local Group self-funded businesses.

Anthem's benefit expense ratio was 88.6% in Q4 2017, reflecting an increase of 140 basis points from 87.2% in Q4 2016. The increase was principally driven by the impact of the one-year waiver of the health insurance tax in 2017.

Anthem's Days in Claims Payable (DCP) was 39.4 days as of December 31, 2017, representing a decrease of 1.1 days from 40.5 days as of September 30, 2017.

Segment Results

During Q4 2017, Anthem's operating gain in the Commercial & Specialty Business segment totaled $71.2 million, down 62.4% from $189.2 million in Q4 2016. The decrease was driven by increased investment spending to support growth initiatives and the impact of the one-year waiver of the health insurance tax in 2017.

Anthem's operating gain in the Government Business segment was $360.8 million in Q4 2017, reflecting a decrease of 31.9%, from $529.9 million in Q4 2016. The decrease reflects increased investment spend to support growth initiatives and the impact of the one-year waiver of the health insurance tax in 2017.

Cash Matters

During Q4 2017, Anthem's operating cash outflow was $1.3 billion, bringing FY17 operating cash flow to $4.2 billion, or 1.1 times net income.

During Q4 2017, the Company repurchased 1.8 million shares of its common stock for $362 million, or a weighted-average price of $205.41. During FY17, Anthem repurchased 10.5 million shares of its common stock for $2.0 billion, or a weighted average price of $189.93. As of December 31, 2017, the Company had approximately $7.2 billion of Board-approved share repurchase authorization remaining.

Outlook

For full year 2018, Anthem is forecasting net income to be greater than $14.28 per share, including approximately $0.72 per share of net unfavorable items. The Company's adjusted net income is expected to be greater than $15.00 per share.

For FY18, Anthem is projecting Medical membership to be in the range of 40.00 million to 40.20 million, fully insured membership is expected to be in the band of 14.80 million to 14.90 million and self-funded membership is expected to be in the range of 25.20 million to 25.30 million.

Anthem is estimating operating revenue to be in the range of $90.5 billion to $91.5 billion for FY18. The Company is anticipating benefit expense ratio to be 84.5% plus or minus 30 basis points and operating cash flow is expected to be greater than $4.0 billion.

Stock Performance Snapshot

February 13, 2018 - At Tuesday's closing bell, Anthem's stock marginally rose 0.29%, ending the trading session at $233.45.

Volume traded for the day: 1.39 million shares.

Stock performance in the last three-month – up 6.95%; previous six-month period – up 22.03%; past twelve-month period – up 42.77%; and year-to-date – up 3.75%

After yesterday's close, Anthem's market cap was at $60.81 billion.

Price to Earnings (P/E) ratio was at 16.25.

The stock has a dividend yield of 1.29%.

The stock is part of the Healthcare sector, categorized under the Health Care Plans industry. This sector was up 0.1% at the end of the session.

Active-Investors:

Active-Investors (A-I) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and Canadian stocks. A-I has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

A-I has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third-party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email info@active-investors.com. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by A-I. A-I is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

A-I, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. A-I, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, A-I, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither A-I nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://active-investors.com/legal-disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@active-investors.com

Phone number: 73 29 92 6381

Office Address: 6, Jalan Kia Peng, Kuala Lumpur, 50450 Kuala Lumpur, Wilayah Persekutuan Kuala Lumpur, Malaysia

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active-Investors

ReleaseID: 489221

Source URL: https://marketersmedia.com/free-research-report-as-anthems-quarterly-revenue-grew-4-5-earnings-more-than-tripled/300931

Source: AccessWire

Release ID: 300931

Our Client

Subscribe and Recieve exclusive insider tips and tricks on Press Release.

Follow Us

Copyright © 2012 - 2018 MarketersMedia – Press Release Distribution Services – News Release Distribution Services. All Rights Reserved.

Powered by Semantics BigData Analytics (SBDA).